Glaxo to Examine Sale of $3.1 Billion India Consumer Unit Stake
GlaxoSmithKline Plc’s Horlicks drink products, center, are displayed in a local grocery store in the Kalahati market area in Siliguri, West Bengal, India (Photographer: Sanjit Das/Bloomberg)  

Glaxo to Examine Sale of $3.1 Billion India Consumer Unit Stake

(Bloomberg) -- U.K. pharmaceutical giant GlaxoSmithKline Plc will examine selling the stake it holds in its Indian consumer health subsidiary, worth about $3.1 billion, as it looks for ways to fina...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.